JEFFREY MOFFETT: Open Payments
NPI 1710135629 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 21 payments from 8 companies in 2025. Trend: 2023 $231 · 2024 $153 · 2025 $372
Food & beverage: $353Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: FARXIGA, JARDIANCE, AIRSUPRA, UBRELVY, NURTEC ODT, Kerendia, MOUNJARO, Symbravo.
Industry payments across MS — which companies pay providers there.
